MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Combination Therapy of Ellagic Acid and Mucuna Pruriens Seeds Extract Improves Rotenone Induced Behavioural, Oxidative and Mitochondrial Deficits in Mice Model of Parkinson’s Disease

    D. Khatri (Pune, India)

    Objective: The present study was designed in order to explore the possible synergistic effect of two highly naturally occurring bio-active compounds viz. Ellagic acid (EA)…
  • 2018 International Congress

    Gait disorders in Parkinson’s disease: 19 observations at the University Hospital Center of Conakry

    F. Sakadi, C. Abass, T. Rahamatou, B. Talibé, N. Woga, B. Kenda, C. Amara (Conakry, Guinea)

    Objective: We report the cases in order to make a clinical and evolutionary evaluation of this pathology. Background: Gait disorders are more and more reported…
  • 2018 International Congress

    ‘PDSAFE’ – A multi-dimensional fall rehabilitation intervention for people with Parkinson’s with specialist physiotherapy training: qualitative exploration of physio’s experiences

    K. Seymour, S. Hulbert, V. Goodwin, L. Rochester, A. Nieuwboer, A. Ashburn (Southampton, United Kingdom)

    Objective: To describe the experiences and views of physiotherapists on the specialist training and delivery of the PDSAFE intervention as part the falls prevention trial.…
  • 2018 International Congress

    ODM-104 and optimized carbidopa dose show beneficial effect on levodopa PK in healthy subjects

    J. Tuunainen, J. Ellmén, M. Vahteristo, A. Holopainen, D. Strugala (Espoo, Finland)

    Objective: To study the dose effects of a novel catechol-O-methyl transferase (COMT) inhibitor ODM-104 and the aromatic L-amino acid decarboxylase (AADC) inhibitor carbidopa on levodopa…
  • 2018 International Congress

    Safety and Efficacy of Levodopa-Carbidopa Monotherapy in Patients with Advanced Parkinson’s Disease

    J. Boyd, C. Zadikoff, M. Siddiqui, J. Benesh, J. Zamudio, W. Robieson, P. Kukreja (Burlington, VT, USA)

    Objective: Evaluate efficacy/safety of levodopa-carbidopa intestinal gel (LCIG) daytime monotherapy (with/without nighttime oral carbidopa/levodopa) vs polytherapy (LCIG with >1 adjunctive therapy) in advanced Parkinson’s disease…
  • 2018 International Congress

    Levodopa Induced Orthostatic Hypotension in Parkinson’s Disease: A Single-Dose Response Study

    K. Thiankhaw, S. Tanprawate, A. Soontornpun, A. Nudsasarn, S. Chankrachang (Chiang Mai, Thailand)

    Objective: To determine the effect and risk factors of a single dose levodopa induced OH in PD Background: Levodopa (LD) is widely recognised as the…
  • 2018 International Congress

    The outcome of directional subthalamic deep brain stimulation in advanced Parkinson’s disease

    M. Koivu, F. Scheperjans, J. Eerola-Rautio, J. Resendiz-Nieves, J. Marjamaa, R. Kivisaari, E. Pekkonen (Helsinki, Finland)

    Objective: To assess the outcome of patients with advanced Parkinson’s disease (PD) treated with directional DBS. Background: Subthalamic deep brain stimulation (STN-DBS) has proved to…
  • 2018 International Congress

    Dysphagia predicts poor outcome in late-stage Parkinson’s disease

    M. Fabbri, D. Abreu, L. Guedes, M. Rosa, A. Antonini, M. Zibetti, L. Lopiano, J. Fereira, M. Coelho (Lisbon, Portugal)

    Objective: to evaluate the clinical progression and prognostic factors of a late-stage PD (LSPD) population. Background: Parkinson’s disease (PD) disability milestones emerge in an exponential…
  • 2018 International Congress

    Movement Disorders as Postinfectious Neurologic Syndromes

    H. Mori (Kurashiki, Okayama, Japan)

    Objective: We shows the three patients which some neurologists diagnosed psychological disorders at first. Their movement disorders are due to postinfectious neurologic syndromes (Epstein-Barr virus…
  • 2018 International Congress

    Movement disorders in mitochondrial disease: Radio clinical correlation in pediatric patients

    R. Zouari, M. Naifar, F. Kamoun, S. Ben Nsir, R. Ben Jemaa, W. Bouchaala, F. Ayadi, C. Triki (Sfax, Tunisia)

    Objective: Investigate the clinical features of movement disorders (MD), as well as brain imaging findings, in order to identify a radio-clinical correlation in mitochondrial diseases…
  • « Previous Page
  • 1
  • …
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley